Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H K Gillespie

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|December 1, 1975
Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesisL E Hollister, H K Gillespie
Life Sciences|January 1, 1990
The benzodiazepine receptor antagonist, flumazenil does not block clinical effects of delta-9-tetrahydrocannabinolL E Hollister, H K Gillespie
Journal of Analytical Toxicology|May 1, 1990
Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinolE Johansson, H K Gillespie, M M Halldin
Psychopharmacology|December 8, 1978
Propranolol in experimentally induced stressS Nakano, H K Gillespie, L E Hollister
Clinical Pharmacology and Therapeutics|January 1, 1978
A model for evaluation of antianxiety drugs with the use of experimentally induced stress: Comparison of nabilone and diazepamS Nakano, H K Gillespie, L E Hollister
The Journal of Clinical Psychiatry|December 1, 1984
Yohimbine and the model anxiety stateS A Henauer, H K Gillespie, L E Hollister
Drug and Alcohol Dependence|August 1, 1981
Aversive effects of naltrexone in subjects not dependent on opiatesL E Hollister, K Johnson, D Boukhabza, et al.
Psychopharmacology|January 1, 1987
Human pharmacology of 1S and 1R enantiomers of delta-3-tetrahydrocannabinolL E Hollister, H K Gillespie, R Mechoulam, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Theophylline antagonizes diazepam-induced psychomotor impairmentS A Henauer, L E Hollister, H K Gillespie, et al.
Science (New York, N.Y.)|May 29, 1970
Marihuana and temporal disintegrationF T Melges, J R Tinklenberg, L E Hollister, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|December 1, 1975
Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesisL E Hollister, H K Gillespie
Life Sciences|January 1, 1990
The benzodiazepine receptor antagonist, flumazenil does not block clinical effects of delta-9-tetrahydrocannabinolL E Hollister, H K Gillespie
Journal of Analytical Toxicology|May 1, 1990
Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinolE Johansson, H K Gillespie, M M Halldin
Psychopharmacology|December 8, 1978
Propranolol in experimentally induced stressS Nakano, H K Gillespie, L E Hollister
Clinical Pharmacology and Therapeutics|January 1, 1978
A model for evaluation of antianxiety drugs with the use of experimentally induced stress: Comparison of nabilone and diazepamS Nakano, H K Gillespie, L E Hollister
The Journal of Clinical Psychiatry|December 1, 1984
Yohimbine and the model anxiety stateS A Henauer, H K Gillespie, L E Hollister
Drug and Alcohol Dependence|August 1, 1981
Aversive effects of naltrexone in subjects not dependent on opiatesL E Hollister, K Johnson, D Boukhabza, et al.
Psychopharmacology|January 1, 1987
Human pharmacology of 1S and 1R enantiomers of delta-3-tetrahydrocannabinolL E Hollister, H K Gillespie, R Mechoulam, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Theophylline antagonizes diazepam-induced psychomotor impairmentS A Henauer, L E Hollister, H K Gillespie, et al.
Science (New York, N.Y.)|May 29, 1970
Marihuana and temporal disintegrationF T Melges, J R Tinklenberg, L E Hollister, et al.
Pageof 2